Nessan Bermingham Ph.D.
Net Worth
Last updated:
What is Nessan Bermingham Ph.D. net worth?
Unfortunately, the net worth of Mr. Nessan Bermingham Ph.D. is not known at this time.
Intellia Therapeutics key executives
Intellia Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew D. Schiermeier (55) Executive Vice President & Chief Operating Officer
- Dr. Derrick J. Rossi Founder & Member of Scientific Advisor Board
- Dr. Jennifer A. Doudna Founder & Member of Scientific Advisor Board
- Dr. John M. Leonard (68) Pres, Chief Executive Officer & Director
- Dr. Laura Sepp-Lorenzino (64) Executive Vice President & Chief Scientific Officer
- Mr. Andrew May Ph.D. Founder and Member of Scientific Advisor Board
- Mr. Glenn G. Goddard (54) Executive Vice President & Chief Financial Officer
- Mr. José E. Rivera (59) Executive Vice President, Gen. Counsel & Company Sec.
- Mr. Nessan Bermingham Ph.D. Founder & Member of Scientific Advisor Board
- Ms. Rachel Haurwitz Ph.D. Co-Founder